Biohaven (BHVN) Secures Agreement From FDA on Initial Pediatric Study Plan for Rimegepant
Tweet Send to a Friend
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced today that the Company has received agreement from the U.S. Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE